Novo Nordisk - ADR
NVO
historical activity
| Quarter | Shares | +/- Shares | Change % | Value($) | % of Total value | Avg Report Price($) |
|---|---|---|---|---|---|---|
| Q3 2025 | 2.4M | +110.1K | ↑4.87% | 131.4M | 1.06% | 55.49 |
| Q2 2025 | 2.3M | +108.6K | ↑5.05% | 155.9M | 1.31% | 69.02 |
| Q1 2025 | 2.1M | = | = | 149.3M | 1.32% | 69.44 |
| Q4 2024 | 2.1M | = | = | 184.9M | 1.63% | 86.02 |
| Q3 2024 | 2.1M | = | = | 256.0M | 2.3% | 119.07 |
| Q2 2024 | 2.1M | = | = | 306.9M | 3.01% | 142.74 |
| Q1 2024 | 2.1M | = | = | 276.1M | 2.72% | 128.40 |
| Q4 2023 | 2.1M | = | = | 222.4M | 2.41% | 103.45 |
| Q3 2023 | 2.1M | +1.1M | ↑100.00% | 195.5M | 2.36% | 90.94 |
| Q2 2023 | 1.1M | = | = | 174.0M | 2.07% | 161.83 |
| Q1 2023 | 1.1M | = | = | 171.1M | 2.17% | 159.14 |
| Q4 2022 | 1.1M | = | = | 145.5M | 1.95% | 135.34 |